Jacobs Levy Equity Management Inc. lessened its position in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 64.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 73,424 shares of the industrial products company's stock after selling 133,616 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.30% of Proto Labs worth $2,156,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Pacer Advisors Inc. raised its holdings in Proto Labs by 44,804.1% during the 3rd quarter. Pacer Advisors Inc. now owns 573,874 shares of the industrial products company's stock worth $16,855,000 after purchasing an additional 572,596 shares during the last quarter. Hotchkis & Wiley Capital Management LLC bought a new stake in shares of Proto Labs during the third quarter worth approximately $8,587,000. Assenagon Asset Management S.A. bought a new stake in shares of Proto Labs during the second quarter worth approximately $7,535,000. Dimensional Fund Advisors LP lifted its holdings in Proto Labs by 13.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,110,566 shares of the industrial products company's stock valued at $34,305,000 after buying an additional 130,670 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in Proto Labs by 32.3% in the second quarter. Renaissance Technologies LLC now owns 435,823 shares of the industrial products company's stock valued at $13,463,000 after acquiring an additional 106,423 shares during the last quarter. Institutional investors and hedge funds own 84.54% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages have commented on PRLB. Cantor Fitzgerald reiterated an "overweight" rating and set a $40.00 target price on shares of Proto Labs in a research report on Monday, November 4th. Craig Hallum upped their price objective on Proto Labs from $30.00 to $36.00 and gave the company a "hold" rating in a report on Monday, November 4th. Finally, Needham & Company LLC restated a "hold" rating on shares of Proto Labs in a report on Friday, November 1st. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $40.33.
Check Out Our Latest Research Report on PRLB
Proto Labs Price Performance
Shares of NYSE PRLB traded up $1.31 during midday trading on Friday, reaching $42.68. 177,399 shares of the stock were exchanged, compared to its average volume of 257,606. Proto Labs, Inc. has a 12 month low of $25.75 and a 12 month high of $42.71. The company has a market capitalization of $1.05 billion, a price-to-earnings ratio of 45.40 and a beta of 1.45. The business has a 50-day simple moving average of $34.02 and a two-hundred day simple moving average of $31.82.
Proto Labs (NYSE:PRLB - Get Free Report) last posted its earnings results on Friday, November 1st. The industrial products company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.15. Proto Labs had a return on equity of 3.49% and a net margin of 4.76%. The firm had revenue of $125.60 million for the quarter, compared to analyst estimates of $121.38 million. During the same period in the previous year, the company posted $0.31 earnings per share. The company's revenue for the quarter was down 3.9% on a year-over-year basis. Equities research analysts expect that Proto Labs, Inc. will post 0.84 earnings per share for the current fiscal year.
Proto Labs Profile
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Recommended Stories
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.